These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia. Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864 [TBL] [Abstract][Full Text] [Related]
6. Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19. Seyhan AU; Doganay F; Yilmaz E; Topal NP; Ak R J Coll Physicians Surg Pak; 2020 Oct; 30(10):153-157. PubMed ID: 33291194 [TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19. O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708 [TBL] [Abstract][Full Text] [Related]
8. Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients. Eftekhar SP; Kazemi S; Barary M; Javanian M; Ebrahimpour S; Ziaei N Cardiovasc Ther; 2021; 2021():6683098. PubMed ID: 33688374 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US. Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851 [TBL] [Abstract][Full Text] [Related]
10. Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. Moschini L; Loffi M; Regazzoni V; Di Tano G; Gherbesi E; Danzi GB Heart Vessels; 2021 Jan; 36(1):115-120. PubMed ID: 32676695 [TBL] [Abstract][Full Text] [Related]
11. Absence of relevant QT interval prolongation in not critically ill COVID-19 patients. Jiménez-Jáimez J; Macías-Ruiz R; Bermúdez-Jiménez F; Rubini-Costa R; Ramírez-Taboada J; Flores PIG; Gallo-Padilla L; García JDM; García CM; Suárez SM; Molina CF; López MÁ; Tercedor L Sci Rep; 2020 Dec; 10(1):21417. PubMed ID: 33293554 [TBL] [Abstract][Full Text] [Related]
12. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation. Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263 [TBL] [Abstract][Full Text] [Related]
13. The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients. Avedissian SN; Rhodes NJ; Ng TMH; Rao AP; Beringer PM Pharmacotherapy; 2019 Jun; 39(6):718-723. PubMed ID: 31045258 [TBL] [Abstract][Full Text] [Related]
14. The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heart. Akkerman-Nijland AM; Möhlmann JE; Akkerman OW; Vd Vaart H; Majoor CJ; Rottier BL; Burgerhof JGM; Hak E; Koppelman GH; Touw DJ Expert Opin Drug Saf; 2021 Aug; 20(8):959-963. PubMed ID: 34030570 [No Abstract] [Full Text] [Related]
15. Azithromycin-induced proarrhythmia and cardiovascular death. Howard PA Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766 [TBL] [Abstract][Full Text] [Related]
16. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic. Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991 [TBL] [Abstract][Full Text] [Related]
17. Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study. van der Sijs H; Kowlesar R; Klootwijk AP; Nelwan SP; Vulto AG; van Gelder T Br J Clin Pharmacol; 2009 Mar; 67(3):347-54. PubMed ID: 19523015 [TBL] [Abstract][Full Text] [Related]
18. An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis. Lenehan PJ; Schramm CM; Collins MS J Cyst Fibros; 2016 Mar; 15(2):192-5. PubMed ID: 26698953 [TBL] [Abstract][Full Text] [Related]
19. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Mayet S; Gossop M; Lintzeris N; Markides V; Strang J Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918 [TBL] [Abstract][Full Text] [Related]
20. Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation. Niedrig D; Maechler S; Hoppe L; Corti N; Kovari H; Russmann S Eur J Clin Pharmacol; 2016 Jul; 72(7):859-67. PubMed ID: 27023463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]